Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated. [PDF]
Micheli G +10 more
europepmc +1 more source
Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies. [PDF]
Komaki S +27 more
europepmc +1 more source
Statin-Associated Immune-Mediated Necrotizing Myopathy With Dual Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) and Anti-OJ Positivity: A Case Report of Fulminant Weakness and Respiratory Failure. [PDF]
Rahman MA +4 more
europepmc +1 more source
Pediatric case of immune-mediated necrotizing myopathy with anti-HMGCR antibodies and dermatomyositis skin rash. [PDF]
Cavillon T +6 more
europepmc +1 more source
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy. [PDF]
Tiniakou E +13 more
europepmc +1 more source
Anti-HMGCR positive immune-mediated necrotizing myopathy with associated neutrophilic urticarial dermatosis: A case report. [PDF]
Fletcher KM +3 more
europepmc +1 more source
Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness. [PDF]
Fink NS, Abubshait L, Deshisky A.
europepmc +1 more source
Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. [PDF]
Llansó L +22 more
europepmc +1 more source

